Bioarray, a leading Spanish genetic diagnostics laboratory, joins CERTANIA, enhancing its global reach and service offerings in the life sciences sector.

Information on the Target

Bioarray, established in 2009 and headquartered in Elche (Alicante), Spain, is a prominent diagnostic and research laboratory renowned for its pioneering work in advanced genetic testing. The company has gained recognition as a trustworthy provider of high-value genetic testing services that merge scientific excellence with technological innovation. Bioarray's expertise lies in molecular diagnostics, utilizing cutting-edge technologies such as array-CGH and Next Generation Sequencing (NGS) to support diverse applications, including reproductive genetics, oncology, and clinical medicine.

With a strong commitment to genomic research, Bioarray offers various services, notably gene expression studies, RNA-sequencing, and tailored bioinformatics solutions. The company operates across Europe, Latin America, and the MENA region, serving clients in over 40 countries while maintaining durable partnerships with public hospitals, private healthcare providers, fertility clinics, and research institutions.

Industry Overview in Spain

The genetic diagnostics industry in Spain has witnessed substantial growth in recent years, spurred by advancements in technology and an increasing demand for personalized medicine. The country's healthcare system places a strong emphasis on early di